The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.

To investigate the influence of analgesic-based midazolam sedation on delirium and outcomes in critically ill patients and to analyze the risk factors of delirium.Single center, prospective randomized controlled trial.A surgical intensive care unit (ICU) in a tertiary care hospital in China.Mechanic...

Full description

Bibliographic Details
Main Authors: Dan Liu, Jie Lyu, Huiying Zhao, Youzhong An
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5598969?pdf=render
id doaj-e34499c5c2da411ea4d72a23c543420b
record_format Article
spelling doaj-e34499c5c2da411ea4d72a23c543420b2020-11-25T01:41:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018431010.1371/journal.pone.0184310The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.Dan LiuJie LyuHuiying ZhaoYouzhong AnTo investigate the influence of analgesic-based midazolam sedation on delirium and outcomes in critically ill patients and to analyze the risk factors of delirium.Single center, prospective randomized controlled trial.A surgical intensive care unit (ICU) in a tertiary care hospital in China.Mechanically ventilated patients requiring sedation.Patients admitted to the surgical intensive care unit who required sedation and were undergoing mechanical ventilation for longer than 24 hours were randomly divided into three groups: 1) the remifentanil group received remifentanil and midazolam, 2) the fentanyl group received fentanyl and midazolam, and 3) the control group received only midazolam. The analgesic effect, sedation depth, and presence of delirium were evaluated. To compare the effect of different therapies on the occurrence of delirium, days of mechanical ventilation, length of the ICU stay, and 28-day mortality were measured along with the risk factors for delirium. A total of 105 patients were enrolled, and 35 patients were included in each group. Compared to the control group, patients who received remifentanil and fentanyl required less midazolam each day (P = 0.038 and <0.001, respectively). Remifentanil has a significant effect on reducing the occurrence of delirium (P = 0.007). The logistic regression analysis of delirium demonstrated that remifentanil (OR 0.230, 95%Cl 0.074-0.711, P = 0.011) is independent protective factors for delirium, and high APACHE II score (OR 1.103, 95%Cl 1.007-1.208, P = 0.036) is the independent risk factor for delirium.Remifentanil and fentanyl can reduce the amount of midazolam required, and remifentanil could further reduce the occurrence of delirium.http://europepmc.org/articles/PMC5598969?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Dan Liu
Jie Lyu
Huiying Zhao
Youzhong An
spellingShingle Dan Liu
Jie Lyu
Huiying Zhao
Youzhong An
The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
PLoS ONE
author_facet Dan Liu
Jie Lyu
Huiying Zhao
Youzhong An
author_sort Dan Liu
title The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
title_short The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
title_full The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
title_fullStr The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
title_full_unstemmed The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial.
title_sort influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: a randomized controlled trial.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description To investigate the influence of analgesic-based midazolam sedation on delirium and outcomes in critically ill patients and to analyze the risk factors of delirium.Single center, prospective randomized controlled trial.A surgical intensive care unit (ICU) in a tertiary care hospital in China.Mechanically ventilated patients requiring sedation.Patients admitted to the surgical intensive care unit who required sedation and were undergoing mechanical ventilation for longer than 24 hours were randomly divided into three groups: 1) the remifentanil group received remifentanil and midazolam, 2) the fentanyl group received fentanyl and midazolam, and 3) the control group received only midazolam. The analgesic effect, sedation depth, and presence of delirium were evaluated. To compare the effect of different therapies on the occurrence of delirium, days of mechanical ventilation, length of the ICU stay, and 28-day mortality were measured along with the risk factors for delirium. A total of 105 patients were enrolled, and 35 patients were included in each group. Compared to the control group, patients who received remifentanil and fentanyl required less midazolam each day (P = 0.038 and <0.001, respectively). Remifentanil has a significant effect on reducing the occurrence of delirium (P = 0.007). The logistic regression analysis of delirium demonstrated that remifentanil (OR 0.230, 95%Cl 0.074-0.711, P = 0.011) is independent protective factors for delirium, and high APACHE II score (OR 1.103, 95%Cl 1.007-1.208, P = 0.036) is the independent risk factor for delirium.Remifentanil and fentanyl can reduce the amount of midazolam required, and remifentanil could further reduce the occurrence of delirium.
url http://europepmc.org/articles/PMC5598969?pdf=render
work_keys_str_mv AT danliu theinfluenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT jielyu theinfluenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT huiyingzhao theinfluenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT youzhongan theinfluenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT danliu influenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT jielyu influenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT huiyingzhao influenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
AT youzhongan influenceofanalgesicbasedsedationprotocolsondeliriumandoutcomesincriticallyillpatientsarandomizedcontrolledtrial
_version_ 1725039111863009280